MARK GIBBS: Open Payments
NPI 1306463930 · GAINESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,103 in 51 payments from 12 companies in 2025. Trend: 2023 $499 · 2024 $938 · 2025 $1,103
Food & beverage: $1,028Education: $76
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $466 |
| ABBVIE INC. | 11 | $221 |
| Amgen Inc. | 4 | $106 |
| UCB, Inc. | 3 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $62 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $20 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
Products named: TREMFYA, SKYRIZI, OTEZLA, Bimzelx, RINVOQ, SPEVIGO, Cabtreo, Rhapsido.
Industry payments across VA — which companies pay providers there.
